Results 11 to 20 of about 50,070 (158)
Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming [PDF]
Molecules, 2020 Processing of certain viral proteins and bacterial toxins by host serine proteases is a frequent and critical step in virulence. The coronavirus spike glycoprotein contains three (S1, S2, and S2′) cleavage sites that are processed by human host proteases. The exact nature of these cleavage sites, and their respective processing proteases, can determine
Elisa Barile +5 more
openaire +3 more sources
Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2 [PDF]
3 Biotech, 2021 The novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has led to a global crisis by infecting millions of people across the globe eventually causing multiple deaths. The prominent player of the virus has been known as the spike protein which enters the host system and leads to the infection.
Aanchal Mathur +5 more
openaire +2 more sources
Closing coronavirus spike glycoproteins by structure-guided design [PDF]
, 2020 The recent spillover of SARS-CoV-2 in the human population resulted in the ongoing COVID-19 pandemic which has already caused 4.9 million infections and more than 326,000 fatalities. To initiate infection the SARS-CoV-2 spike (S) glycoprotein promotes attachment to the host cell surface, determining host and tissue tropism, and fusion of the viral and ...
McCallum, Matthew +3 more
openaire +2 more sources
Therapeutic targeting of coronavirus spike glycoprotein priming [PDF]
, 2020 Abstract Processing of certain viral proteins and bacterial toxins by host serine proteases is a frequent and critical step in virulence. The coronavirus spike glycoprotein contains three (S1, S2, and S2’) cleavage sites that are processed by human host proteases.
Maurizio Pellecchia +5 more
openaire +1 more source
Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris [PDF]
Virus Genes, 2008 To establish a rapid and economical method for the expression of viral proteins in high yield and purity by Pichia pastoris, the S protein of the SARS-CoV was selected in this study. Six S glycoprotein fragments were expressed in Escherichia coli BL21 and yeast KM71H strains.
Chuck, Chi-Pang +5 more
openaire +2 more sources
An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus [PDF]
Frontiers in Molecular Biosciences, 2021 The novel coronavirus originated in December 2019 in Hubei, China. This contagious disease named as COVID-19 resulted in a massive expansion within 6 months by spreading to more than 213 countries. Despite the availability of antiviral drugs for the treatment of various viral infections, it was concluded by the WHO that there is no medicine to treat ...
Muthu Kumaradoss Kathiravan +5 more
openaire +3 more sources
Incorporation of Spike and Membrane Glycoproteins into Coronavirus Virions [PDF]
Viruses, 2015 The envelopes of coronaviruses (CoVs) contain primarily three proteins; the two major glycoproteins spike (S) and membrane (M), and envelope (E), a non-glycosylated protein. Unlike other enveloped viruses, CoVs bud and assemble at the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC).
Makoto Ujike, Fumihiro Taguchi
openaire +3 more sources
High-Potency Polypeptide-based Interference for Coronavirus Spike Glycoproteins [PDF]
, 2021 Abstract The world is experiencing an unprecedented coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 spike protein-based vaccines are currently the main preventive agent to fight against the virus.
Qinghua Wang, Jianpeng Ma, Adam Acevedo
openaire +1 more source
Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirus [PDF]
Virologica Sinica, 2010 A group of SARS-like coronaviruses (SL-CoV) have been identified in horseshoe bats. Despite SL-CoVs and SARS-CoV share identical genome structure and high-level sequence similarity, SL-CoV does not bind to the same cellular receptor as for SARS-CoV and the N-terminus of the S proteins only share 64% amino acid identity, suggesting there are fundamental
Hou, Yu-xuan +5 more
openaire +2 more sources
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer [PDF]
Nature, 2016 The tremendous pandemic potential of coronaviruses was demonstrated twice in the past few decades by two global outbreaks of deadly pneumonia. Entry of coronaviruses into cells is mediated by the transmembrane spike glycoprotein S, which forms a trimer carrying receptor-binding and membrane fusion functions.
Walls, Alexandra +7 more
openaire +5 more sources